Definium Therapeutics, Inc. (DFTX) Debt Components
- 2026-06-30: Long-term Debt, Excluding Current MaturitiesUSD $36.47M; Debt Instrument, Fee AmountUSD $656.00K; Long-term Debt, GrossUSD $36.50M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $689.00K.
- 2026-03-31: Long-term Debt, Excluding Current MaturitiesUSD $40.77M; Debt Instrument, Fee AmountUSD $525.00K; Long-term Debt, GrossUSD $41.00M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $752.00K.
- 2025-12-31: Long-term Debt, Excluding Current MaturitiesUSD $40.58M; Debt Instrument, Fee AmountUSD $394.00K; Long-term Debt, GrossUSD $41.00M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $815.00K.
- 2025-09-30: Long-term Debt, Excluding Current MaturitiesUSD $40.38M; Debt Instrument, Fee AmountUSD $263.00K; Long-term Debt, GrossUSD $41.00M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $877.00K.
Definium Therapeutics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Excluding Current Maturities USD | Debt Instrument, Fee Amount USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|
| 2026-06-30 | $36.47M | $656.00K | $36.50M | $689.00K |
| 2026-03-31 | $40.77M | $525.00K | $41.00M | $752.00K |
| 2025-12-31 | $40.58M | $394.00K | $41.00M | $815.00K |
| 2025-09-30 | $40.38M | $263.00K | $41.00M | $877.00K |
| 2025-06-30 | $41.19M | $131.00K | $42.00M | $940.00K |
| 2025-03-31 | $22.04M | $603.00K | $22.00M | $567.00K |
| 2024-12-31 | $21.85M | $482.00K | $22.00M | $628.00K |
| 2024-09-30 | $24.31M | (m) | $25.00M | $689.00K |
| 2024-06-30 | $24.25M | (m) | $25.00M | $749.00K |
| 2024-03-31 | $14.19M | (m) | $15.00M | $810.00K |
| 2023-12-31 | $14.13M | (m) | $15.00M | $871.00K |
| 2023-09-30 | $14.07M | (m) | $15.00M | $932.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |